Treatment of inflammatory and metal storage diseases of the liver.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001815:Bloodletting; D002614:Chelating Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003300:Copper / Q000378:metabolism; D005260:Female; D006432:Hemochromatosis / Q000628:therapy; D006505:Hepatitis / Q000188:drug therapy / Q000628:therapy*; D006519:Hepatitis, Alcoholic / Q000188:drug therapy; D006527:Hepatolenticular Degeneration / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008105:Liver Cirrhosis, Biliary / Q000628:therapy; D008107:Liver Diseases; D008664:Metal Metabolism, Inborn Errors / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D002614:Chelating Agents; D007502:Iron Chelating Agents; D003300:Copper; D001379:Azathioprine